Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. (KTTA) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 41 transactions totaling $626.8K, demonstrating a bullish sentiment with $626.8K in net insider flow. The most recent transaction on Nov 28, 2025 involved a transaction of 33,333 shares valued at $25.0K.
KTTA Insider Activity Summary
Who Is Buying KTTA Stock?
No significant insider buying has been recorded for KTTA in the recent period.
Who Is Selling KTTA Stock?
No significant insider selling has been recorded for KTTA in the recent period.
Is Pasithea Therapeutics Corp. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KTTA is bullish with an Insider Alignment Score of 100/100 and a net flow of $626.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KTTA Frequently Asked Questions
Understanding KTTA Insider Activity
Insider trading at Pasithea Therapeutics Corp. (KTTA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading KTTA stock, having executed 41 transactions in the past 90 days. The most active insider is Fund, Lp Camac (Executive), who has made 6 transactions totaling $365.4K.
Related Tools
Track Pasithea Therapeutics Corp. Insider Activity
Get notified when executives and directors at KTTA file new Form 4 transactions